Design to come?

WP_Post Object
(
    [ID] => 1916
    [post_author] => 3
    [post_date] => 2023-09-07 14:12:28
    [post_date_gmt] => 2023-09-07 19:12:28
    [post_content] => 
    [post_title] => Intensity Therapeutics Receives Orphan Drug Designation for the three key ingredients in INT230-6 for the Treatment of Soft Tissue Sarcoma
    [post_excerpt] => 
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => intensity-therapeutics-receives-orphan-drug-designation-for-the-three-key-ingredients-in-int230-6-for-the-treatment-of-soft-tissue-sarcoma
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2023-10-16 14:14:12
    [post_modified_gmt] => 2023-10-16 19:14:12
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://vcapital.com/?post_type=news&p=1916
    [menu_order] => 0
    [post_type] => news
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
)